Cell Line Genetics — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Founded in 2004 and headquartered in Madison, Wisconsin, Cell Line Genetics has established itself as a niche leader in genetic characterization services for cell lines. The company's core business model is providing essential quality assurance services and reagents to ensure the genetic integrity and authenticity of research cell lines, a critical need in stem cell, cancer, and basic biomedical research. Its technology platform integrates classical cytogenetics with modern genomic techniques, and it serves a global clientele, including prestigious institutions like the Salk Institute. As a private company, it operates in the diagnostics and research tools sector, generating revenue through fee-for-service work and product sales.

Genetics & GenomicsDiagnostics

Technology Platform

Integrated suite of cytogenetic and molecular analysis techniques including Array Comparative Genomic Hybridization (aCGH), G-Band Karyotyping, Fluorescence In Situ Hybridization (FISH), Short Tandem Repeat (STR) analysis, and PCR-based mycoplasma detection. Also offers proprietary CLG StemCheck™ FISH probes and the StemCloud™ secure data delivery platform.

Opportunities

Growing mandates for cell line authentication from journals and funding agencies create a stable demand driver.

Expansion of the stem cell therapy and biologics manufacturing fields presents a growing need for specialized genetic quality control services.

There is an opportunity to develop more standardized, off-the-shelf assay kits from custom service work.

Risk Factors

Operates in a niche market with growth limited by the overall size of the research quality control sector.

Faces competition from university core facilities and larger commercial genomic service providers.

Core technologies risk being supplemented or replaced by next-generation sequencing-based methods.

Competitive Landscape

Competes with other specialized cytogenetics service labs, university core facilities offering similar techniques, and larger, diversified contract research organizations (CROs) like Charles River Laboratories that have cell line authentication service divisions. Differentiation is based on deep expertise in multi-species analysis, a focus on stem cells, and a comprehensive, integrated service menu.

More companies in Cell & Gene Therapy →More companies in United States →